Login Register Cart 0
Generic placeholder image

Current Vascular Pharmacology

Editor-in-Chief

ISSN (Print): 1570-1611
ISSN (Online): 1875-6212

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Review Article

Vascular Damage in Obesity and Diabetes: Highlighting Links Between Endothelial Dysfunction and Metabolic Disease in Zebrafish and Man

Author(s): Lucas Moritz Wiggenhauser and Jens Kroll*

Volume 17, Issue 5, 2019

Page: [476 - 490] Pages: 15

DOI: 10.2174/1570161116666181031101413

Price: $65

Abstract

Endothelial dysfunction is an initial pathophysiological mechanism of vascular damage and is further recognized as an independent predictor of negative prognosis in diabetes-induced micro- and macrovascular complications. Insight into the capability of zebrafish to model metabolic disease like obesity and type II diabetes has increased and new evidence on the induction of vascular pathologies in zebrafish through metabolic disease is available. Here, we raise the question, if zebrafish can be utilized to study the initial impairments of vascular complications in metabolic disorders. In this review, we focus on the advances made to develop models of obesity and type II diabetes in zebrafish, discuss the key points and characteristics of these models, while highlighting the available information linked to the development of endothelial dysfunction in zebrafish and man. We show that larval and adult zebrafish develop metabolic dysregulation in the settings of obesity and diabetes, exhibiting pathophysiological mechanisms, which mimic the human condition. The most important genes related to endothelial dysfunction are present in zebrafish and further display similar functions as in mammals. Several suggested contributors to endothelial dysfunction found in these models, namely hyperinsulinaemia, hyperglycaemia, hyperlipidaemia and hyperleptinaemia are highlighted and the available data from zebrafish are summarised. Many underlying processes of endothelial dysfunction in obesity and diabetes are fundamentally present in zebrafish and provide ground for the assumption, that zebrafish can develop endothelial dysfunction. Conservation of basic biological mechanisms is established for zebrafish, but focused investigation on the subject is now needed as validation and particularly more research is necessary to understand the differences between zebrafish and man. The available data demonstrate the relevance of zebrafish as a model for metabolic disease and their ability to become a proponent for the investigation of vascular damage in the settings of obesity and diabetes.

Keywords: Endothelial function, endothelial dysfunction, diabetes mellitus, microvascular complications, macrovascular complications, obesity, zebrafish, danio rerio.

« Previous Next »
Graphical Abstract

[1]
Geisler R, Kohler A, Dickmeis T, Strahle U. Archiving of zebrafish lines can reduce animal experiments in biomedical research. EMBO Rep 2017; 18: 1-2.
[2]
Lidster K, Readman GD, Prescott MJ, Owen SF. International survey on the use and welfare of zebrafish Danio rerio in research. J Fish Biol 2017; 90: 1891-905.
[3]
Felzien LK. Integration of a zebrafish research project into a molecular biology course to support critical thinking and course content goals. Biochem Mol Biol Educ 2016; 44: 565-73.
[4]
Seto SW, Kiat H, Lee SM, et al. Zebrafish models of cardiovascular diseases and their applications in herbal medicine research. Eur J Pharmacol 2015; 768: 77-86.
[5]
Tamplin OJ, White RM, Jing L, et al. Small molecule screening in zebrafish: swimming in potential drug therapies. Wiley Interdiscip Rev Dev Biol 2012; 1: 459-68.
[6]
Gore AV, Monzo K, Cha YR, Pan W, Weinstein BM. Vascular development in the zebrafish. Cold Spring Harb Perspect Med 2012; 2a006684
[7]
Heckler K, Kroll J. Zebrafish as a model for the study of microvascular complications of diabetes and their mechanisms. Int J Mol Sci 2017; 18pii:E2002
[8]
Rajendran P, Rengarajan T, Thangavel J, et al. The vascular endothelium and human diseases. Int J Biol Sci 2013; 9: 1057-69.
[9]
Shi Y, Vanhoutte PM. Macro- and microvascular endothelial dysfunction in diabetes. J Diabetes 2017; 9: 434-49.
[10]
Davenport AP, Hyndman KA, Dhaun N, et al. Endothelin. Pharmacol Rev 2016; 68: 357-418.
[11]
Sena CM, Pereira AM, Seica R. Endothelial dysfunction - a major mediator of diabetic vascular disease. Biochim Biophys Acta 2013; 1832: 2216-31.
[12]
Knowles RG, Moncada S. Nitric oxide synthases in mammals. Biochem J 1994; 298: 249-58.
[13]
Forstermann U, Sessa WC. Nitric oxide synthases: Regulation and function. Eur Heart J 2012; 33: 829-37.
[14]
Lepiller S, Franche N, Solary E, Chluba J, Laurens V. Comparative analysis of zebrafish NOS2A and NOS2B genes. Gene 2009; 445: 58-65.
[15]
Wittmann C, Reischl M, Shah AH, et al. A zebrafish drug-repurposing screen reveals SGC-dependent and sgc-independent pro-inflammatory activities of nitric oxide. PLoS One 2015; 10e0137286
[16]
Sykes BG, Van Steyn PM, Vignali JD, et al. The relationship between estrogen and nitric oxide in the prevention of cardiac and vascular anomalies in the developing zebrafish (Danio Rerio). Brain Sci 2016; 6pii:E51
[17]
Fritsche R, Schwerte T, Pelster B. Nitric oxide and vascular reactivity in developing zebrafish, Danio Rerio. Am J Physiol Regul Integr Comp Physiol 2000; 279: 2200-7.
[18]
Dahl Ejby Jensen L, Cao R, et al. Nitric oxide permits hypoxia-induced lymphatic perfusion by controlling arterial-lymphatic conduits in zebrafish and glass catfish. Proc Natl Acad Sci USA 2009; 106: 18408-13.
[19]
Gray C, Packham IM, Wurmser F, et al. Ischemia is not required for arteriogenesis in zebrafish embryos. Arterioscler Thromb Vasc Biol 2007; 27: 2135-41.
[20]
Morris SM Jr. Arginine metabolism: Boundaries of our knowledge. J Nutr 2007; 137: 1602-9.
[21]
Closs EI, Simon A, Vekony N, Rotmann A. Plasma membrane transporters for arginine. J Nutr 2004; 134: 2752-9.
[22]
Durante W, Johnson FK, Johnson RA. Arginase: A critical regulator of nitric oxide synthesis and vascular function. Clin Exp Pharmacol Physiol 2007; 34: 906-11.
[23]
Lee SJ, Park SH, Chung JF, Choi W, Huh HK. Homocysteine-induced peripheral microcirculation dysfunction in zebrafish and its attenuation by L-arginine. Oncotarget 2017; 8: 58264-71.
[24]
Wright PA, Campbell A, Morgan RL, Rosenberger AG, Murray BW. Dogmas and controversies in the handling of nitrogenous wastes: Expression of arginase type I and II genes in rainbow trout: Influence of fasting on liver enzyme activity and mRNA levels in juveniles. J Exp Biol 2004; 207: 2033-42.
[25]
Fuentealba Gonzalez P, Llanos-Rivera A, Carvajal Baeza N, Uribe Perez E. Xenobiotic-induced changes in the arginase activity of zebrafish (Danio Rerio) eleutheroembryo. Environ Toxicol Chem 2011; 30: 2285-91.
[26]
Mitchell JA, Ali F, Bailey L, Moreno L, Harrington LS. Role of nitric oxide and prostacyclin as vasoactive hormones released by the endothelium. Exp Physiol 2008; 93: 141-7.
[27]
Jia G, Durante W, Sowers JR. Endothelium-derived hyperpolarizing factors: A potential therapeutic target for vascular dysfunction in obesity and insulin resistance. Diabetes 2016; 65: 2118-20.
[28]
Yeh HC, Wang LH. Profiling of prostanoids in zebrafish embryonic development. Prostaglandins Leukot Essent Fatty Acids 2006; 75: 397-402.
[29]
Chen D, Tang J, Wan Q, et al. E-prostanoid 3 receptor mediates sprouting angiogenesis through suppression of the protein kinase a/beta-catenin/Notch pathway. Arterioscler Thromb Vasc Biol 2017; 37: 856-66.
[30]
Pini B, Grosser T, Lawson JA, Price TS, Pack MA, FitzGerald GA. Prostaglandin E synthases in zebrafish. Arterioscler Thromb Vasc Biol 2005; 25: 315-20.
[31]
Gao X, Martinez-Lemus LA, Zhang C. Endothelium-derived hyperpolarizing factor and diabetes. World J Cardiol 2011; 3: 25-31.
[32]
Campbell WB, Gauthier KM. Inducible endothelium-derived hyperpolarizing factor: Role of the 15-lipoxygenase-EDHF pathway. J Cardiovasc Pharmacol 2013; 61: 176-87.
[33]
Tang G, Yang G, Jiang B, Ju Y, Wu L, Wang RH. (2)S is an endothelium-derived hyperpolarizing factor. Antioxid Redox Signal 2013; 19: 1634-46.
[34]
Landgraf K, Schuster S, Meusel A, et al. Short-term overfeeding of zebrafish with normal or high-fat diet as a model for the development of metabolically healthy versus unhealthy obesity. BMC Physiol 2017; 17: 4.
[35]
Flynn EJ, Trent CM, Rawls JF. Ontogeny and nutritional control of adipogenesis in zebrafish (Danio Rerio). J Lipid Res 2009; 50: 1641-52.
[36]
Imrie D, Sadler KC. White adipose tissue development in zebrafish is regulated by both developmental time and fish size. Dev Dyn 2010; 239: 3013-23.
[37]
Minchin JE, Rawls JF. In vivo analysis of white adipose tissue in zebrafish. Methods Cell Biol 2011; 105: 63-86.
[38]
Song Y, Cone RD. Creation of a genetic model of obesity in a teleost. FASEB J 2007; 21: 2042-9.
[39]
Gut P, Reischauer S, Stainier DYR, Arnaout R. Little fish, big data: Zebrafish as a model for cardiovascular and metabolic disease. Physiol Rev 2017; 97: 889-938.
[40]
Minchin JEN, Rawls JF. Elucidating the role of plexin D1 in body fat distribution and susceptibility to metabolic disease using a zebrafish model system. Adipocyte 2017; 6: 277-83.
[41]
Carnovali M, Luzi L, Terruzzi I, Banfi G, Mariotti M. Metabolic and bone effects of high-fat diet in adult zebrafish. Endocrine 2018; 61: 317-26.
[42]
Oka T, Nishimura Y, Zang L, et al. Diet-induced obesity in zebrafish shares common pathophysiological pathways with mammalian obesity. BMC Physiol 2010; 10: 21.
[43]
Liu C, Gates KP, Fang L, et al. Apoc2 loss-of-function zebrafish mutant as a genetic model of hyperlipidemia. Dis Model Mech 2015; 8: 989-98.
[44]
Fang L, Liu C, Miller YI. Zebrafish models of dyslipidemia: Relevance to atherosclerosis and angiogenesis. Transl Res 2014; 163: 99-108.
[45]
den Broeder MJ, Moester MJB, Kamstra JH, et al. Altered adipogenesis in zebrafish larvae following high fat diet and chemical exposure is visualised by stimulated raman scattering microscopy. Int J Mol Sci 2017; 18(4)pii:E894
[46]
Clifton JD, Lucumi E, Myers MC, et al. Identification of novel inhibitors of dietary lipid absorption using zebrafish. PLoS One 2010; 5(8)e12386
[47]
Forn-Cuni G, Varela M, Fernandez-Rodriguez CM, Figueras A, Novoa B. Liver immune responses to inflammatory stimuli in a diet-induced obesity model of zebrafish. J Endocrinol 2015; 224: 159-70.
[48]
Michel M, Page-McCaw PS, Chen W, Cone RD. Leptin signaling regulates glucose homeostasis, but not adipostasis, in the zebrafish. Proc Natl Acad Sci USA 2016; 113: 3084-9.
[49]
Kang T, Lu W, Xu W, et al. MicroRNA-27 (miR-27) targets prohibitin and impairs adipocyte differentiation and mitochondrial function in human adipose-derived stem cells. J Biol Chem 2013; 288: 34394-402.
[50]
Hus CC, Lai CY, Lin CY, et al. MicroRNA-27b depletion enhances endotrophic and intravascular lipid accumulation and induces adipocyte hyperplasia in zebrafish. Int J Mol Sci 2017; 19pii:E93
[51]
Yeh KY, Lai CY, Lin CY, Hsu CC, Lo CP, Her GM. ATF4 overexpression induces early onset of hyperlipidaemia and hepatic steatosis and enhances adipogenesis in zebrafish. Sci Rep 2017; 7: 16362.
[52]
Chu CY, Chen CF, Rajendran RS, et al. Overexpression of Akt1 enhances adipogenesis and leads to lipoma formation in zebrafish. PLoS One 2012; 7(5)e36474
[53]
Jurczyk A, Roy N, Bajwa R, et al. Dynamic glucoregulation and mammalian-like responses to metabolic and developmental disruption in zebrafish. Gen Comp Endocrinol 2011; 170: 334-45.
[54]
Field HA, Dong PD, Beis D, Stainier DY. Formation of the digestive system in zebrafish. II. Pancreas morphogenesis. Dev Biol 2003; 261: 197-208.
[55]
Schlegel A, Gut P. Metabolic insights from zebrafish genetics, physiology, and chemical biology. Cell Mol Life Sci 2015; 72: 2249-60.
[56]
Graham GV, Conlon JM, Abdel-Wahab YH, Gault VA, Flatt PR. Evaluation of the insulinotropic and glucose-lowering actions of zebrafish GIP in mammalian systems: Evidence for involvement of the GLP-1 receptor. Peptides 2018; 100: 182-9.
[57]
Toyoshima Y, Monson C, Duan C, et al. The role of insulin receptor signaling in zebrafish embryogenesis. Endocrinology 2008; 149: 5996-6005.
[58]
Zhang D, Wang J, Zhou C, Xiao W. Zebrafish AKT2 is essential for survival, growth, bone development, and glucose homeostasis. Mech Dev 2017; 143: 42-52.
[59]
Marin-Juez R, Jong-Raadsen S, Yang S, Spaink HP. Hyperinsulinemia induces insulin resistance and immune suppression via Ptpn6/Shp1 in zebrafish. J Endocrinol 2014; 222: 229-41.
[60]
Xu E, Charbonneau A, Rolland Y, et al. Hepatocyte-specific Ptpn6 deletion protects from obesity-linked hepatic insulin resistance. Diabetes 2012; 61: 1949-58.
[61]
Riddle MR, Aspiras AC, Gaudenz K, et al. Insulin resistance in cavefish as an adaptation to a nutrient-limited environment. Nature 2018; 555: 647-51.
[62]
Zoncu R, Efeyan A, Sabatini DM. mTOR: From growth signal integration to cancer, diabetes and ageing. Nat Rev Mol Cell Biol 2011; 12: 21-35.
[63]
Meng XH, Chen B, Zhang JP. Intracellular insulin and impaired autophagy in a zebrafish model and a cell model of type 2 diabetes. Int J Biol Sci 2017; 13: 985-95.
[64]
Craig PM, Moon TW. Fasted zebrafish mimic genetic and physiological responses in mammals: A model for obesity and diabetes? Zebrafish 2011; 8: 109-17.
[65]
Ran G, Ying L, Li L, et al. Resveratrol ameliorates diet-induced dysregulation of lipid metabolism in zebrafish (Danio Rerio). PLoS One 2017; 12e0180865
[66]
Zang L, Shimada Y, Nishimura N. Development of a novel zebrafish model for type 2 diabetes mellitus. Sci Rep 2017; 7: 1461.
[67]
Connaughton VP, Baker C, Fonde L, Gerardi E, Slack C. Alternate immersion in an external glucose solution differentially affects blood sugar values in older versus younger zebrafish adults. Zebrafish 2016; 13: 87-94.
[68]
Moss JB, Koustubhan P, Greenman M, Parsons MJ, Walter I, Moss LG. Regeneration of the pancreas in adult zebrafish. Diabetes 2009; 58: 1844-51.
[69]
Pisharath H, Rhee JM, Swanson MA, Leach SD, Parsons MJ. Targeted ablation of beta cells in the embryonic zebrafish pancreas using E. coli nitroreductase. Mech Dev 2007; 124: 218-29.
[70]
Ninov N, Hesselson D, Gut P, Zhou A, Fidelin K, Stainier DY. Metabolic regulation of cellular plasticity in the pancreas. Curr Biol 2013; 23: 1242-50.
[71]
Yang BY, Zhai G, Gong YL, et al. Different physiological roles of insulin receptors in mediating nutrient metabolism in zebrafish. Am J Physiol Endocrinol Metab 2017; 315: 38-51.
[72]
Kimmel RA, Dobler S, Schmitner N, Walsen T, Freudenblum J, Meyer D. Diabetic pdx1-mutant zebrafish show conserved responses to nutrient overload and anti-glycemic treatment. Sci Rep 2015; 5: 14241.
[73]
Maddison LA, Joest KE, Kammeyer RM, Chen W. Skeletal muscle insulin resistance in zebrafish induces alterations in beta-cell number and glucose tolerance in an age- and diet-dependent manner. Am J Physiol Endocrinol Metab 2015; 308: 662-9.
[74]
Leo CH, Woodman OL. Flavonols in the prevention of diabetes-induced vascular dysfunction. J Cardiovasc Pharmacol 2015; 65: 532-44.
[75]
Schinzari F, Tesauro M, Cardillo C. Endothelial and perivascular adipose tissue abnormalities in obesity-related vascular dysfunction: Novel targets for treatment. J Cardiovasc Pharmacol 2017; 69: 360-8.
[76]
Copps KD, White MF. Regulation of insulin sensitivity by serine/threonine phosphorylation of insulin receptor substrate proteins IRS1 and IRS2. Diabetologia 2012; 55: 2565-82.
[77]
Jotic A, Milicic T, Covickovic Sternic N, et al. Decreased insulin sensitivity and impaired fibrinolytic activity in type 2 diabetes patients and nondiabetics with ischemic stroke. Int J Endocrinol 2015; 2015934791
[78]
Schneider DJ, Sobel BE. PAI-1 and diabetes: A journey from the bench to the bedside. Diabetes Care 2012; 35: 1961-7.
[79]
El Husseny MW, Mamdouh M, Shaban S, et al. Adipokines: Potential therapeutic targets for vascular dysfunction in type II diabetes mellitus and obesity. J Diabetes Res 2017; 20178095926
[80]
Gorissen M, Bernier NJ, Nabuurs SB, Flik G, Huising MO. Two divergent leptin paralogues in zebrafish (Danio Rerio) that originate early in teleostean evolution. J Endocrinol 2009; 201: 329-39.
[81]
Mania M, Maruccio L, Russo F, et al. Expression and distribution of leptin and its receptors in the digestive tract of DIO (diet-induced obese) zebrafish. Ann Anat 2017; 212: 37-47.
[82]
Liu Q, Chen Y, Copeland D, et al. Expression of leptin receptor gene in developing and adult zebrafish. Gen Comp Endocrinol 2010; 166: 346-55.
[83]
Yu RM, Chu DL, Tan TF, et al. Leptin-mediated modulation of steroidogenic gene expression in hypoxic zebrafish embryos: Implications for the disruption of sex steroids. Environ Sci Technol 2012; 46: 9112-9.
[84]
Rodriguez AJ, Nunes Vdos S, Mastronardi CA, Neeman T, Paz-Filho GJ. Association between circulating adipocytokine concentrations and microvascular complications in patients with type 2 diabetes mellitus: A systematic review and meta-analysis of controlled cross-sectional studies. J Diabetes Complications 2016; 30: 357-67.
[85]
Dalman MR, Liu Q, King MD, Bagatto B, Londraville RL. Leptin expression affects metabolic rate in zebrafish embryos (D. Rerio). Front Physiol 2013; 4: 160.
[86]
Kim JA, Montagnani M, Chandrasekran S, Quon MJ. Role of lipotoxicity in endothelial dysfunction. Heart Fail Clin 2012; 8: 589-607.
[87]
Prieto D. Editorial: Vascular dysfunction in obesity and insulin resistance. Curr Vasc Pharmacol 2014; 12: 401-2.
[88]
Gimbrone MA, Garcia-Cardena G. Endothelial cell dysfunction and the pathobiology of atherosclerosis. Circ Res 2016; 118: 620-36.
[89]
Lee SJ, Choi W, Seo E, Yeom E. Association of early atherosclerosis with vascular wall shear stress in hypercholesterolemic zebrafish. PLoS One 2015; 10e0142945
[90]
Capiotti KM, Antonioli R Jr, Kist LW, Bogo MR, Bonan CD, Da Silva RS. Persistent impaired glucose metabolism in a zebrafish hyperglycemia model. Comp Biochem Physiol B Biochem Mol Biol 2014; 171: 58-65.
[91]
Funk SD, Yurdagul A, Orr AW. Hyperglycemia and endothelial dysfunction in atherosclerosis: Lessons from type 1 diabetes. Int J Vasc Med 2012; 2012569654
[92]
Kang MC, Kim KN, Chaminda Lakmal HH, et al. Octaphlorethol A isolated from Ishige foliacea prevents and protects against high glucose-induced oxidative damage in vitro and in vivo. Environ Toxicol Pharmacol 2014; 38: 607-15.
[93]
Alomari MA, Khabour OF, Maikano A, Alawneh K. Vascular function and brain-derived neurotrophic factor: The functional capacity factor. Vasc Med 2015; 20: 518-26.
[94]
Krabbe KS, Nielsen AR, Krogh-Madsen R, et al. Brain-Derived Neurotrophic Factor (BDNF) and type 2 diabetes. Diabetologia 2007; 50: 431-8.
[95]
Montalbano G, Mania M, Guerrera MC, et al. Morphological differences in adipose tissue and changes in BDNF/Trkb expression in brain and gut of a diet induced obese zebrafish model. Ann Anat 2016; 204: 36-44.
[96]
Wang Z, Mao Y, Cui T, Tang D, Wang XL. Impact of a combined high cholesterol diet and high glucose environment on vasculature. PLoS One 2013; 8e81485
[97]
Burgansky-Eliash Z, Nelson DA, Bar-Tal OP, Lowenstein A, Grinvald A, Barak A. Reduced retinal blood flow velocity in diabetic retinopathy. Retina 2010; 30: 765-73.
[98]
Serbanovic-Canic J, de Luca A, Warboys C, et al. Zebrafish model for functional screening of flow-responsive genes. Arterioscler Thromb Vasc Biol 2017; 37: 130-43.
[99]
Jung SH, Kim YS, Lee YR, Kim JS. High glucose-induced changes in hyaloid-retinal vessels during early ocular development of zebrafish: a short-term animal model of diabetic retinopathy. Br J Pharmacol 2016; 173: 15-26.
[100]
Tio RA, Wijpkema J, Tan ES, et al. Reduction of endothelial dysfunction following VEGF gene therapy. Neth Heart J 2005; 13: 139-41.
[101]
Chen Y, Wang JJ, Li J, et al. Activating transcription factor 4 mediates hyperglycaemia-induced endothelial inflammation and retinal vascular leakage through activation of STAT3 in a mouse model of type 1 diabetes. Diabetologia 2012; 55: 2533-45.
[102]
Lenna S, Han R, Trojanowska M. Endoplasmic reticulum stress and endothelial dysfunction. IUBMB Life 2014; 66: 530-7.
[103]
Carnovali M, Luzi L, Banfi G, Mariotti M. Chronic hyperglycemia affects bone metabolism in adult zebrafish scale model. Endocrin 2016; 54: 808-17.
[104]
Jorgens K, Stoll SJ, Pohl J, et al. High tissue glucose alters intersomitic blood vessels in zebrafish via methylglyoxal targeting the VEGF receptor signaling cascade. Diabetes 2015; 64: 213-25.
[105]
Shimada Y, Kuninaga S, Ariyoshi M, et al. E2F8 promotes hepatic steatosis through FABP3 expression in diet-induced obesity in zebrafish. Nutr Metab (Lond) 2015; 12: 17.
[106]
Tainaka T, Shimada Y, Kuroyanagi J, et al. Transcriptome analysis of anti-fatty liver action by Campari tomato using a zebrafish diet-induced obesity model. Nutr Metab (Lond) 2011; 8: 88.
[107]
Karanth S, Zinkhan EK, Hill JT, Yost HJ, Schlegel A. FOXN3 regulates hepatic glucose utilization. Cell Rep 2016; 15: 2745-55.
[108]
Ragvin A, Moro E, Fredman D, et al. Long-range gene regulation links genomic type 2 diabetes and obesity risk regions to HHEX, SOX4, and IRX3. Proc Natl Acad Sci USA 2010; 107: 775-80.

Rights & Permissions Print Cite
Article Metrics
131
11
© 2024 Bentham Science Publishers | Privacy Policy